Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: Application to brain tumors.
Saved in:
| Title: | Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: Application to brain tumors. |
|---|---|
| Authors: | Zhou, Jinyuan1 (AUTHOR) jzhou2@jhmi.edu, Zaiss, Moritz2,3 (AUTHOR), Knutsson, Linda1,4,5 (AUTHOR), Sun, Phillip Zhe6 (AUTHOR), Ahn, Sung Soo7 (AUTHOR), Aime, Silvio8 (AUTHOR), Bachert, Peter9,10 (AUTHOR), Blakeley, Jaishri O.11 (AUTHOR), Cai, Kejia12 (AUTHOR), Chappell, Michael A.13,14 (AUTHOR), Chen, Min15 (AUTHOR), Gochberg, Daniel F.16,17,18 (AUTHOR), Goerke, Steffen9 (AUTHOR), Heo, Hye‐Young1 (AUTHOR), Jiang, Shanshan1 (AUTHOR), Jin, Tao19 (AUTHOR), Kim, Seong‐Gi20 (AUTHOR), Laterra, John11,21 (AUTHOR), Paech, Daniel22,23 (AUTHOR), Pagel, Mark D.24 (AUTHOR) |
| Source: | Magnetic Resonance in Medicine. Aug2022, Vol. 88 Issue 2, p546-574. 29p. |
| Subjects: | Brain tumors, Diagnostic imaging, Magnetic resonance imaging, Brain imaging |
| Abstract: | Amide proton transfer‐weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed‐on standards in the imaging community. Therefore, the results acquired from different research centers are difficult to compare, which hampers uniform clinical application and interpretation. This paper reviews current clinical APTw imaging approaches and provides a rationale for optimized APTw brain tumor imaging at 3 T, including specific recommendations for pulse sequences, acquisition protocols, and data processing methods. We expect that these consensus recommendations will become the first broadly accepted guidelines for APTw imaging of brain tumors on 3 T MRI systems from different vendors. This will allow more medical centers to use the same or comparable APTw MRI techniques for the detection, characterization, and monitoring of brain tumors, enabling multi‐center trials in larger patient cohorts and, ultimately, routine clinical use. [ABSTRACT FROM AUTHOR] |
| Copyright of Magnetic Resonance in Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Amide proton transfer‐weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed‐on standards in the imaging community. Therefore, the results acquired from different research centers are difficult to compare, which hampers uniform clinical application and interpretation. This paper reviews current clinical APTw imaging approaches and provides a rationale for optimized APTw brain tumor imaging at 3 T, including specific recommendations for pulse sequences, acquisition protocols, and data processing methods. We expect that these consensus recommendations will become the first broadly accepted guidelines for APTw imaging of brain tumors on 3 T MRI systems from different vendors. This will allow more medical centers to use the same or comparable APTw MRI techniques for the detection, characterization, and monitoring of brain tumors, enabling multi‐center trials in larger patient cohorts and, ultimately, routine clinical use. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 07403194 |
| DOI: | 10.1002/mrm.29241 |
